INOVIO PHARMACEUTICALS INC (INO)

US45773H4092 - Common Stock

10.57  +0.45 (+4.4%)

After market: 10.38 -0.19 (-1.8%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
832.01K10.26M1.77M7.41M4.11M
Minority Interest Expense
N/A0.000.001.06M1.19M
Operating Expenses
134.26M277.84M302.99M131.50M115.22M
Research and Development
86.68M187.65M249.24M94.25M88.02M
Selling, General, and Administrative Expenses
47.58M90.19M53.75M37.25M27.20M
Operating Income
-133.43M-267.57M-301.22M-124.09M-111.11M
Interest Income/Expense
13.53M-6.22M-2.35M-42.81M-10.20M
Other Income/Expense
-4.71M-3.86M340.00K-700.00K500.00K
Non Recurring Items
-10.51M0.000.004.71M0.00
Income Before Taxes
-135.12M-277.65M-303.22M-162.89M-120.81M
Income Tax
N/AN/A0.000.00-260.00K
Net Income
-135.12M-279.82M-303.66M-166.41M-119.36M
EBITDA
-130.66M-263.41M-297.66M-120.50M-106.44M
 
Per Share Data
EPS Diluted Total Ops
-6.09-1.17-1.45-1.07-1.21
Non GAAP EPS
-6.16-3.49-1.45-1.10-1.23
 
Statistics
Profit Margin
-16239.87%-2727.29%-17155.93%-2245.75%-2904.14%
Operating Profit Margin
-16036.67%-2607.89%-17018.08%-1674.63%-2703.41%

All data in USD

Charts